Your session is about to expire
← Back to Search
Timing of Tourniquet Release, A Prospective Randomized Trial
N/A
Waitlist Available
Research Sponsored by Orlando Health, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks, 10 weeks, 6 months.
Awards & highlights
No Placebo-Only Group
Summary
This will be a prospective randomized clinical trial comparing clinical outcome measures in patients who undergo elective upper extremity surgery when tourniquet is dropped prior to closure as opposed to when tourniquet is dropped after closure. The study will compare objective data obtained intraoperatively as well as standard clinical outcome measures such as pain scores at routine follow up.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 weeks, 10 weeks, 6 months.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks, 10 weeks, 6 months.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Hematoma assessment
Quick DASH form
Satisfaction with surgery
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: A: Closure without releasing the tourniquet.Active Control1 Intervention
Tourniquet is dropped after closure.
Group II: B: Releasing the tourniquet and then closing the incisionActive Control1 Intervention
Tourniquet is dropped prior to closure.
Find a Location
Who is running the clinical trial?
Orlando Health, Inc.Lead Sponsor
31 Previous Clinical Trials
14,903 Total Patients Enrolled